Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

clover health investments corp - CLOV

CLOV

Close Chg Chg %
1.82 0.00 0.00%

Pre-Market

1.82

0.00 (0.00%)

Volume: 3.61M

Last Updated:

Mar 25, 2026, 4:00 PM EDT

Trade Now

Company Overview: clover health investments corp - CLOV

CLOV Key Data

Open

$1.85

 Day Range

1.80 - 1.88

52 Week Range

1.78 - 3.92

 Market Cap

$954.89M

Shares Outstanding

524.67M

 Public Float

396.00M

Beta

2.16

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.17

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

6.17M

  

CLOV Performance

1 Week
 
 -3.70%
 
1 Month
 
 -12.92%
 
3 Months
 
 -27.49%
 
1 Year
 
 -49.30%
 
5 Years
 
 -76.02%
 

CLOV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 2.983
Number of Ratings 3 Current Quarters Estimate 0.069
FY Report Date 03 / 2026 Current Year's Estimate 0.043
Last Quarter’s Earnings -0.051 Median PE on CY Estimate N/A
Year Ago Earnings 0.036 Next Fiscal Year Estimate 0.047
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 3 2 3
Mean Estimate 0.07 0.04 0.04 0.05
High Estimates 0.07 0.06 0.08 0.09
Low Estimate 0.07 0.01 0.01 0.01
Coefficient of Variance 1.32 64.36 122.66 86.63

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 2 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Clover Health Investments Corp - CLOV

Date Name Shares Transaction Value
Mar 6, 2026 Brady Patrick Priest CEO of Home Care 1,998,584 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $2.17 per share 4,336,927.28
Jan 12, 2026 Vivek Garipalli Director 3,512,196 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 12, 2026 Vivek Garipalli Director 1,856,247 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.59 per share 4,807,679.73
Aug 13, 2025 Andrew Toy Chief Executive Officer; Director 10,474,512 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.18 per share 22,834,436.16
Apr 8, 2025 Jamie L. Reynoso CEO, Medicare Advantage 3,263,768 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.51 per share 11,455,825.68

Clover Health Investments Corp in the News